PSI's Pharmaceutical Statistics Journal Club on PSI’s Special Interest Groups (SIGs)


PSI present a special edition of the Pharmaceutical Statistics Journal Club on PSI’s Special Interest Groups (SIGs)

Toxicology SIG
Philip Jarvis, AstraZeneca and Helena Geys, Janssen Pharmaceutica
An assessment of the statistical methods used to analyse toxicology studies
Co-author: Jim Saul, Mike Aylott, Simon Bate and John Sherington;Volume 10, Issue 6, Pages 477-484, November/December 2011

Biomarker SIG
Martin Jenkins, AstraZeneca
A statistician's perspective on biomarkers in drug development
Co-author: Aiden Flynn, Trevor Smart, Chris Harbron, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis and James Matcham; Volume 10, Issue 6, Pages 494-507, November/December 2011

Chair: Graham Healey, Oncimmune Ltd.

For each of these published Pharmaceutical Statistics papers there will be a 20 minute presentation by the author followed by 20-25 minute discussion.

Papers available to view from 20th September to 18th October on and presentation slides will be available there from 24th September to download before the JC. Journal subscribers can access papers at any time. Podcasts will be available shortly after the JC to download from the above website.
Open to PSI and non-PSI members – no need to pre-register.

Related Topics

Related Publications

Related Content

Site Footer


This website is provided by John Wiley & Sons Limited, The Atrium, Southern Gate, Chichester, West Sussex PO19 8SQ (Company No: 00641132, VAT No: 376766987)

Published features on are checked for statistical accuracy by a panel from the European Network for Business and Industrial Statistics (ENBIS)   to whom Wiley and express their gratitude. This panel are: Ron Kenett, David Steinberg, Shirley Coleman, Irena Ograjenšek, Fabrizio Ruggeri, Rainer Göb, Philippe Castagliola, Xavier Tort-Martorell, Bart De Ketelaere, Antonio Pievatolo, Martina Vandebroek, Lance Mitchell, Gilbert Saporta, Helmut Waldl and Stelios Psarakis.